1. Home
  2. TUYA vs CGEM Comparison

TUYA vs CGEM Comparison

Compare TUYA & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUYA
  • CGEM
  • Stock Information
  • Founded
  • TUYA 2014
  • CGEM 2016
  • Country
  • TUYA China
  • CGEM United States
  • Employees
  • TUYA N/A
  • CGEM N/A
  • Industry
  • TUYA Computer Software: Prepackaged Software
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TUYA Technology
  • CGEM Health Care
  • Exchange
  • TUYA Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • TUYA 1.6B
  • CGEM 482.7M
  • IPO Year
  • TUYA 2021
  • CGEM 2021
  • Fundamental
  • Price
  • TUYA $2.63
  • CGEM $6.42
  • Analyst Decision
  • TUYA Strong Buy
  • CGEM Strong Buy
  • Analyst Count
  • TUYA 1
  • CGEM 8
  • Target Price
  • TUYA $3.49
  • CGEM $27.25
  • AVG Volume (30 Days)
  • TUYA 2.0M
  • CGEM 546.5K
  • Earning Date
  • TUYA 08-26-2025
  • CGEM 11-06-2025
  • Dividend Yield
  • TUYA 4.19%
  • CGEM N/A
  • EPS Growth
  • TUYA N/A
  • CGEM N/A
  • EPS
  • TUYA 0.05
  • CGEM N/A
  • Revenue
  • TUYA $318,493,000.00
  • CGEM N/A
  • Revenue This Year
  • TUYA $11.71
  • CGEM N/A
  • Revenue Next Year
  • TUYA $12.86
  • CGEM N/A
  • P/E Ratio
  • TUYA $53.19
  • CGEM N/A
  • Revenue Growth
  • TUYA 22.29
  • CGEM N/A
  • 52 Week Low
  • TUYA $1.28
  • CGEM $6.37
  • 52 Week High
  • TUYA $4.63
  • CGEM $18.62
  • Technical
  • Relative Strength Index (RSI)
  • TUYA 55.39
  • CGEM 34.56
  • Support Level
  • TUYA $2.46
  • CGEM $6.44
  • Resistance Level
  • TUYA $2.73
  • CGEM $6.76
  • Average True Range (ATR)
  • TUYA 0.13
  • CGEM 0.41
  • MACD
  • TUYA 0.00
  • CGEM -0.11
  • Stochastic Oscillator
  • TUYA 39.29
  • CGEM 1.68

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: